Related Experiment Video
Updated: Jun 27, 2026
02:22
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
When is it safe to discontinue AED treatment?
Peter Camfield1, Carol Camfield
1Department of Pediatrics, Dalhousie University, IWK Health Centre, Halifax, Nova Scotia, Canada. camfield@dal.ca
Epilepsia
|December 18, 2008
Summary
Discontinuing antiepileptic drugs (AEDs) after achieving seizure freedom is a significant decision. Many children and adults remain seizure-free after stopping AEDs, but timing and individual factors are crucial for success.
Area of Science:
- Neurology
- Clinical Pharmacology
Background:
- Epilepsy management often involves long-term antiepileptic drug (AED) treatment.
- Discontinuing AEDs is a complex decision for patients and clinicians after achieving seizure control.
Purpose of the Study:
- To evaluate the success rates and influencing factors for discontinuing AED treatment in seizure-free children and adults.
- To provide guidance on optimal timing for AED discontinuation based on seizure-freedom duration.
Main Methods:
- Analysis of seizure recurrence rates after tapering and stopping AEDs in pediatric and adult populations.
- Exploration of factors such as seizure-freedom duration and epilepsy syndrome in predicting successful AED discontinuation.
Main Results:
- Approximately 69% of children and 61% of adults remain seizure-free after AED discontinuation.
- Seizure-freedom duration may influence success rates in adults, but not typically in children.
- Risk factors for recurrence can aid in predicting discontinuation success.
Conclusions:
- Children with 1-2 years of seizure freedom may be candidates for AED discontinuation.
- Adults may benefit from waiting at least 4 years of seizure freedom before considering AED discontinuation.
- Careful consideration of recurrence risks and individual patient factors is essential.
Related Concept Videos
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...